Latest News

Filters close
Newswise: Cancer Care Can’t Wait
Released: 27-Jul-2020 8:00 AM EDT
Cancer Care Can’t Wait
Rutgers Cancer Institute of New Jersey

Further delaying your preventative cancer care may cause more harm than good. Expert from Rutgers Cancer Institute of New Jersey explains how most colorectal cancers can be prevented through regular screenings, and it is safe to get your screenings, even during these difficult times.

Newswise: Donate Blood to Save a Life
Released: 14-Jul-2020 8:00 AM EDT
Donate Blood to Save a Life
Rutgers Cancer Institute of New Jersey

Stay-at-home orders during the COVID-19 pandemic has resulted in an increased need for blood and platelets. Rutgers Cancer Institute expert shares why right now is an important time to donate blood to ensure a sufficient blood supply for patients in need.

Newswise: July is National UV Safety Month
Released: 6-Jul-2020 8:00 AM EDT
July is National UV Safety Month
Rutgers Cancer Institute of New Jersey

July is UV Safety Month, the perfect time to raise awareness about the risk of developing sun-related skin cancer. Rutgers Cancer Institute expert shares tips about how to reduce skin cancer risk during the summer months when UV rays are the strongest.

Newswise: American Cancer Society Updates Guidelines for Cancer Prevention
Released: 24-Jun-2020 1:40 PM EDT
American Cancer Society Updates Guidelines for Cancer Prevention
Rutgers Cancer Institute of New Jersey

The American Cancer Society recently updated its nutrition and physical activity guidelines for cancer prevention. These updates focus on increasing physical activity and developing healthy eating patterns at every age, with an emphasis on maintaining a healthy body weight through all stages of life.

Newswise: Exploring a Potential Link between Tissue Match Genes and COVID-19
Released: 22-Jun-2020 8:20 AM EDT
Exploring a Potential Link between Tissue Match Genes and COVID-19
Rutgers Cancer Institute of New Jersey

A new study led by Rutgers Cancer Institute of New Jersey and the Gift of Life Marrow Registry seeks to determine how different versions of immune-vital genes screened for transplant matching may shape who develops or resists COVID-19.

Newswise: Cancer Care Can’t Wait
Released: 15-Jun-2020 8:35 AM EDT
Cancer Care Can’t Wait
Rutgers Cancer Institute of New Jersey

Many people are worried about things in their lives that have been put on hold. For some women, this includes an annual mammogram. Safeguards have been put in place at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health facilities so women can safely continue to get this potentially life-saving screening or any follow-up care that may be needed.

Newswise: Cancer Care Can’t Wait
Released: 8-Jun-2020 8:05 AM EDT
Cancer Care Can’t Wait
Rutgers Cancer Institute of New Jersey

Cancer patients might still have heightened concerns over rescheduling a postponed surgery or scheduling a new surgery right now due to COVID-19. Rutgers Cancer Institute of New Jersey expert explains how surgical care precautions have been instituted to ensure the safety of patients and medical staff.

Newswise: Assessing Data Integrity in Times of COVID
Released: 4-Jun-2020 9:50 AM EDT
Assessing Data Integrity in Times of COVID
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute expert discusses guarding data integrity for the first remdesivir double-blind placebo-controlled clinical trial addressing treatment for COVID-19.

Newswise: Men’s Health Month: Top 5 Tips for Dad this Father’s Day
Released: 2-Jun-2020 12:25 PM EDT
Men’s Health Month: Top 5 Tips for Dad this Father’s Day
Rutgers Cancer Institute of New Jersey

June is Men’s Health Month, a national recognition that raises awareness about health care for men. It is also the month during which we celebrate Father’s Day. In celebration of these observances, an expert from Rutgers Cancer Institute of New Jersey shares information on cancer screenings and other important tips to encourage dad to lead a healthy lifestyle all year round.

Newswise: Your Cancer Care is too Important to Wait
Released: 1-Jun-2020 8:00 AM EDT
Your Cancer Care is too Important to Wait
Rutgers Cancer Institute of New Jersey

Minimizing your exposure to COVID-19 doesn’t require sacrificing cancer care or preventive services. Rutgers Cancer Institute of New Jersey and RWJBarnabas Health are taking extra precautions to ensure that patients can continue to receive exceptional care close to home.

Newswise: Building an International Consortium to Enhance Decision Making in Hodgkin Lymphoma
Released: 29-May-2020 4:05 PM EDT
Building an International Consortium to Enhance Decision Making in Hodgkin Lymphoma
Rutgers Cancer Institute of New Jersey

Findings and the development of a new international consortium known as HoLISTIC are being shared as part of a poster presentation at the virtual 2020 American Society for Clinical Oncology Annual Meeting taking place this week.

Newswise: Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor of Cancer Programs Receives Prestigious National Award
Released: 27-May-2020 12:25 PM EDT
Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor of Cancer Programs Receives Prestigious National Award
Rutgers Cancer Institute of New Jersey

Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been selected as the 2020 Gold Medal Award winner by the American Society for Radiation Oncology (ASTRO), a prestigious national award recognizing individuals who have made outstanding lifetime contributions in the field of radiation oncology.

Newswise:Video Embedded are-there-any-programs-for-quitting-tobacco
VIDEO
Released: 19-May-2020 10:05 AM EDT
Are there any Programs for Quitting Tobacco?
Rutgers Cancer Institute of New Jersey

For this 2020 World No Tobacco Day, experts from the Rutgers Tobacco Dependence Program discuss New Jersey quit centers and how quitting tobacco can benefit one during cancer treatment.

Newswise: Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia
Released: 12-May-2020 10:50 AM EDT
Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey

Researchers from Rutgers Cancer Institute of New Jersey along with collaborators from Princeton University identify a new drug that has therapeutic effect against the aggressive hematological disease T-cell acute lymphoblastic leukemia.

Newswise: Superior Progression-Free Survival Associated with Continuous Targeted Therapy Combination for BRAF-mutated Melanoma
27-Apr-2020 9:00 AM EDT
Superior Progression-Free Survival Associated with Continuous Targeted Therapy Combination for BRAF-mutated Melanoma
Rutgers Cancer Institute of New Jersey

Results from a randomized phase 2 clinical trial examining the targeted therapy drugs dabrafenib and tremetinib in both continuous and intermittent treatment of patients with BRAF-mutated melanoma show continuous dosing yields superior progression free survival. A Rutgers Cancer Institute of New Jersey investigator shares more on the work presented at the opening plenary session of the virtual AACR Annual Meeting.

Newswise: Finding Credible Cancer Education Resources during the COVID-19 Pandemic
Released: 15-Apr-2020 8:50 AM EDT
Finding Credible Cancer Education Resources during the COVID-19 Pandemic
Rutgers Cancer Institute of New Jersey

While most public, hospital and academic libraries are closed to visitors due to the COVID-19 pandemic, there is a wealth of information available online, especially for cancer patients seeking disease specific information. Rutgers Cancer Institute of New Jersey's medical librarian shares some tips.

Newswise: Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19
Released: 3-Apr-2020 1:35 PM EDT
Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is not limited to cancer patients is exploring hydroxychloroquine and azithromycin.

Newswise: Rutgers Cancer Institute of New Jersey Research Shows Autophagy Impacts Stress Response Pathways Promoting Survival in Laboratory Models
18-Mar-2020 4:00 PM EDT
Rutgers Cancer Institute of New Jersey Research Shows Autophagy Impacts Stress Response Pathways Promoting Survival in Laboratory Models
Rutgers Cancer Institute of New Jersey

Research from investigators at Rutgers Cancer Institute of New Jersey shows that a cellular process known as autophagy promotes survival in mouse models by suppressing oxidative stress and a tumor suppressor known as p53.

Newswise: Addition of Immunotherapy to Standard Treatment for Advanced Stage Non-Small Cell Lung Cancer is Safe and Tolerable as First-Line Therapy
18-Feb-2020 4:05 PM EST
Addition of Immunotherapy to Standard Treatment for Advanced Stage Non-Small Cell Lung Cancer is Safe and Tolerable as First-Line Therapy
Rutgers Cancer Institute of New Jersey

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer (NSCLC).

Newswise:Video Embedded february-is-cancer-prevention-month
VIDEO
Released: 4-Feb-2020 3:20 PM EST
February is Cancer Prevention Month
Rutgers Cancer Institute of New Jersey

Along with a healthy lifestyle, regular screening can help with the prevention of cancer. Rutgers Cancer Institute of New Jersey experts share additional information during this Cancer Prevention Month.

Newswise:Video Embedded cervical-cancer-awareness-month
VIDEO
Released: 2-Jan-2020 3:00 PM EST
Cervical Cancer Awareness Month
Rutgers Cancer Institute of New Jersey

January is Cervical Cancer Awareness Month. A Rutgers Cancer Institute of New Jersey expert shares insight on prevention and early detection of this disease.

Newswise:Video Embedded new-year-s-resolution-quitting-smoking
VIDEO
Released: 17-Dec-2019 10:15 AM EST
New Year's Resolution: Quitting Smoking
Rutgers Cancer Institute of New Jersey

An expert from the Rutgers Tobacco Dependence Program shares info and resources on how to quit smoking in the new year.

Newswise: Novel Cell-Based Therapy Induces Cell Death in Sensitive and Resistant Non-Hodgkin Lymphoma Models
Released: 16-Dec-2019 8:05 AM EST
Novel Cell-Based Therapy Induces Cell Death in Sensitive and Resistant Non-Hodgkin Lymphoma Models
Rutgers Cancer Institute of New Jersey

Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are sensitive or resistant to standard therapies.

Newswise: Analysis of Different Treatment Strategies for Non-Invasive Breast Cancer Shows Radiation Treatment Alone is Cost-Effective
Released: 11-Dec-2019 2:05 PM EST
Analysis of Different Treatment Strategies for Non-Invasive Breast Cancer Shows Radiation Treatment Alone is Cost-Effective
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey investigators evaluated all treatment strategies for both standard-risk and good-risk ductal carcinoma in-situ and found the most commonly recommended combination treatment for DCIS represents low-value care, while radiation therapy alone was cost-effective.

Newswise: Small Mutations Identified through Deep DNA Sequencing for AML and MDS
Released: 9-Dec-2019 5:05 PM EST
Small Mutations Identified through Deep DNA Sequencing for AML and MDS
Rutgers Cancer Institute of New Jersey

Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. These may help further guide treatment decision making for patients.

Newswise: Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery
Released: 9-Dec-2019 4:20 PM EST
Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery
Rutgers Cancer Institute of New Jersey

Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported cosmetic outcomes.

Newswise: Likelihood of Prenatal Screening for Blood Disorders Varies Between Type of Healthcare Provider
Released: 5-Dec-2019 9:00 AM EST
Likelihood of Prenatal Screening for Blood Disorders Varies Between Type of Healthcare Provider
Rutgers Cancer Institute of New Jersey

A Rutgers Cancer Institute of New Jersey investigator and other collaborators examined prenatal screening practices for blood disorders between different types of care providers and found different variations in prenatal guidance.

Newswise: Addition of Post-Transplant Chemotherapy to Standard Immune Treatment Shows Increase of Allogeneic Transplant Patients in Remission
Released: 5-Dec-2019 8:45 AM EST
Addition of Post-Transplant Chemotherapy to Standard Immune Treatment Shows Increase of Allogeneic Transplant Patients in Remission
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey investigators compared outcomes for allogeneic stem cell transplant patients when post-transplant cyclophosphamide (PCy) was added as part of standard treatment than if standard treatment was given alone. Results showed an increase in the number of patients who were free of disease and off immunosuppression at one-year in the PCy cohort.

Newswise: Rutgers Cancer Institute Researchers Identify Novel Gene Associated with Prognosis in Aggressive form of Ovarian Cancer
Released: 5-Dec-2019 8:00 AM EST
Rutgers Cancer Institute Researchers Identify Novel Gene Associated with Prognosis in Aggressive form of Ovarian Cancer
Rutgers Cancer Institute of New Jersey

Investigators at Rutgers Cancer Institute of New Jersey have determined that an overabundance of a novel gene known as ADNP in an aggressive form of ovarian cancer may serve as a prognostic tool.

Newswise: Retrospective Analysis Identifies Need for Better Classification of Rare Lymphoma
Released: 4-Dec-2019 8:00 AM EST
Retrospective Analysis Identifies Need for Better Classification of Rare Lymphoma
Rutgers Cancer Institute of New Jersey

In what is believed to be one of the largest studies of a rare disorder known as primary cutaneous gamma delta T-cell lymphoma, Rutgers Cancer Institute investigators and other collaborators examined characteristics, treatment patterns and outcomes and determined accurate diagnosis of the disease requires ongoing analysis.

Newswise: $250K Grant Supports Exploration of Tumor Microenvironment in Lung Cancer
Released: 3-Dec-2019 1:00 PM EST
$250K Grant Supports Exploration of Tumor Microenvironment in Lung Cancer
Rutgers Cancer Institute of New Jersey

The GO2 Foundation for Lung Cancer has awarded $250,000 to investigators at Rutgers Cancer Institute of New Jersey and Princeton University toward the identification and development of novel strategies to address treatment resistance in non-small cell lung cancer.

Newswise: Calcium Signaling Identified as Exploitable Target in Addressing Drug Resistance to Non-Hodgkin Lymphoma Treatment
Released: 2-Dec-2019 2:35 PM EST
Calcium Signaling Identified as Exploitable Target in Addressing Drug Resistance to Non-Hodgkin Lymphoma Treatment
Rutgers Cancer Institute of New Jersey

Gene expression profiling and other analyses conducted by Rutgers Cancer Institute of New Jersey researchers and colleagues examining drug resistance to a common antibody therapy for non-Hodgkin lymphoma have identified calcium signaling as a novel and exploitable target in overcoming this treatment obstacle. Results are being presented at the American Society of Hematology Annual Meeting.

Newswise:Video Embedded handling-holiday-stress
VIDEO
Released: 25-Nov-2019 12:20 PM EST
Handling Holiday Stress
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey social worker Deborah Leif, MSW, LCSW offers some tips for cancer patients and caregivers on how to deal with stress related to the holiday season.

Newswise:Video Embedded healthy-holiday-eating
VIDEO
Released: 25-Nov-2019 11:55 AM EST
Healthy Holiday Eating
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey registered dietitian, Kristin Waldron, RD, CSO reminds us about eating healthy this holiday season as part of a cancer preventive lifestyle.

Newswise: $150K Pledge from Om Foundation to Support Pediatric Cancer Research at Rutgers Cancer Institute of New Jersey
Released: 25-Nov-2019 8:00 AM EST
$150K Pledge from Om Foundation to Support Pediatric Cancer Research at Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey

A $150,000 pledge from the Om Foundation will aid investigators at Rutgers Cancer Institute of New Jersey in examining a certain type of medication that impacts gene activity in the treatment of a form of pediatric brain cancer.

Newswise: $2.3 Million in American Cancer Society Grants Awarded to Rutgers Cancer Institute Researchers
Released: 19-Nov-2019 8:00 AM EST
$2.3 Million in American Cancer Society Grants Awarded to Rutgers Cancer Institute Researchers
Rutgers Cancer Institute of New Jersey

More than $2.3 million in Research Scholar Grants from the American Cancer Society have been awarded to three Rutgers Cancer Institute of New Jersey researchers to examine cell metabolism and tumor formation in forms of breast cancer, lung cancer and leukemia.

Newswise: Examining Molecular Evolution and Impact of Treatment in a Common Form of Leukemia
Released: 11-Nov-2019 2:05 PM EST
Examining Molecular Evolution and Impact of Treatment in a Common Form of Leukemia
Rutgers Cancer Institute of New Jersey

A Rutgers Cancer Institute of New Jersey researcher has received a $600,000 Translational Award from the V Foundation for Cancer Research to study treatment impact on chronic lymphocytic leukemia.

Newswise:Video Embedded november-is-lung-cancer-awareness-month5
VIDEO
Released: 1-Nov-2019 10:55 AM EDT
November is Lung Cancer Awareness Month
Rutgers Cancer Institute of New Jersey

Experts from the Rutgers Tobacco Dependence Program share more about the causes and risk factors for lung cancer, which include smoking. At focus is prevention, including tobacco cessation.

Newswise: New Nursing Leader Named to Rutgers Cancer Institute of New Jersey and RWJBarnabas Health
Released: 1-Nov-2019 10:05 AM EDT
New Nursing Leader Named to Rutgers Cancer Institute of New Jersey and RWJBarnabas Health
Rutgers Cancer Institute of New Jersey

Reaffirming its commitment to continued growth and excellence, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health welcome Carolyn Hayes, PhD, RN, NEA-BC, as the new Chief Nursing Officer, RWJBarnabas, Oncology Services and Rutgers Cancer Institute.

Newswise: Oncology Pharmacists: An Essential Partner in the Cancer Journey
Released: 18-Oct-2019 8:00 AM EDT
Oncology Pharmacists: An Essential Partner in the Cancer Journey
Rutgers Cancer Institute of New Jersey

One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey expert shares more on their role in patient care.

Newswise:Video Embedded debunking-breast-cancer-myths2
VIDEO
Released: 14-Oct-2019 7:00 AM EDT
Debunking Breast Cancer Myths
Rutgers Cancer Institute of New Jersey

M. Michele Blackwood, MD, FACS, chief of breast surgery at Rutgers Cancer Institute of New Jersey and medical director/Northern regional director of breast services at RWJBarnabas Health, clears up some misconceptions about breast cancer.

Newswise:Video Embedded can-you-avoid-breast-cancer
VIDEO
Released: 7-Oct-2019 8:00 AM EDT
Can you Avoid Breast Cancer?
Rutgers Cancer Institute of New Jersey

M. Michele Blackwood, MD, FACS, chief of breast surgery at Rutgers Cancer Institute of New Jersey and medical director/Northern regional director of breast services at RWJBarnabas Health, shares expertise on breast cancer prevention and advances in breast cancer care.

Newswise: Detecting Neurocognitive Change in Pediatric Cancer Patients
Released: 1-Oct-2019 10:05 AM EDT
Detecting Neurocognitive Change in Pediatric Cancer Patients
Rutgers Cancer Institute of New Jersey

Although cure rates for children with cancer are increasing, cancer treatments can cause permanent deterioration of brain functions leading to impairments in attention, concentration, memory and learning. With the aid of a $3.4 million NIH grant, a Rutgers Cancer Institute of New Jersey investigator and others are exploring an approach that would detect these changes among children with acute lymphoblastic leukemia early during treatment. The goal is to identify a subset of patients who would benefit from a behavioral intervention or treatment clinical trial.

Newswise:Video Embedded risk-factors-and-screening-for-breast-cancer
VIDEO
Released: 30-Sep-2019 1:05 PM EDT
Risk Factors and Screening for Breast Cancer
Rutgers Cancer Institute of New Jersey

M. Michele Blackwood, MD, FACS, chief of breast surgery at Rutgers Cancer Institute of New Jersey and medical director/Northern regional director of breast services at RWJBarnabas Health, shares expertise on breast cancer risk factors and screening.

Newswise: Lumpectomy for Breast Cancer with Attention to Cosmetic Results
Released: 25-Sep-2019 2:05 PM EDT
Lumpectomy for Breast Cancer with Attention to Cosmetic Results
Rutgers Cancer Institute of New Jersey

As more women live with breast cancer, minimization of significant deformity in the breast after breast preservation is increasingly gaining attention. A Rutgers Cancer Institute of New Jersey surgical oncologist shares some insight.

Newswise:Video Embedded what-is-ovarian-cancer
VIDEO
Released: 18-Sep-2019 2:05 PM EDT
What is Ovarian Cancer?
Rutgers Cancer Institute of New Jersey

Ovarian Cancer is expected to impact 22,000 U.S. women this year. Rutgers Cancer Institute of New Jersey Gynecologic Oncologist Dr. Mihae Song shares some facts during this Ovarian Cancer Awareness Month.

Newswise:Video Embedded what-is-thyroid-cancer
VIDEO
Released: 18-Sep-2019 2:05 PM EDT
What is Thyroid Cancer?
Rutgers Cancer Institute of New Jersey

September is Thyroid Cancer Awareness Month and Dr. Amanda Laird, Chief of Endocrine Surgery at Rutgers Cancer Institute of New Jersey shares information on types of thyroid cancer, how it is diagnosed and treatment options.

Newswise: Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients
Released: 17-Sep-2019 4:20 PM EDT
Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients
Rutgers Cancer Institute of New Jersey

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

Newswise:Video Embedded back-to-school2
VIDEO
Released: 30-Aug-2019 11:05 AM EDT
Back to School!
Rutgers Cancer Institute of New Jersey

From maintaining regular check-ups and keeping up to date with recommended vaccinations to a good diet and exercise, some simple tips can help keep youngsters healthy as they head back to class - and are cancer preventive too.

Newswise: Leukemia: Not Just One Disease
Released: 30-Aug-2019 8:05 AM EDT
Leukemia: Not Just One Disease
Rutgers Cancer Institute of New Jersey

An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.


Showing results

150 of 571

close
0.45781